Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell
Clinical trial NCT03180281 · UNKNOWN
Trial details
- NCT number
- NCT03180281
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2020-01-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.